Promyelocytic Leukemia (PML) Protein Plays Important Roles in Regulating Cell Adhesion, Morphology, Proliferation and Migration

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tang, Mei Kuen ^a   Liang, Yong Jia ^b   Chan, John Yeuk Hon ^b   Wong, Sing Wan ^a   Chen, Elve ^a   Yao, Yao ^a   Gan, Jingyi ^a   Xiao, Lihai ^a   Leung, Hin Cheung ^a   Kung, Hsiang Fu ^a   Wang, Hua ^a   Lee, Kenneth Ka Ho ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCYCLIN BINDING PROTEIN; CELL PROTEIN; CITRON RHO INTERACTING KINASE; COFILIN 1; CYTOKINE INDUCED APOPTOSIS INHIBITOR 1; FAMILY WITH SEQUENCE SIMILARITY 50 MEMBER A; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 1; LIPOCORTIN 4; N MYC DOWNSTREAM REGULATED 1 GENE PROTEIN; PDGFA ASSOCIATED PROTEIN 1; POLYCYTIDYLIC ACID BINDING PROTEIN 2; PROMYELOCYTIC LEUKEMIA PROTEIN; RAS SUPPRESSOR PROTEIN 1; STATHMIN; STATHMIN 1; SUMO 2 PROTEIN; TRIPLE FUNCTION DOMAIN PROTEIN; TUMOR PROTEIN D52 LIKE 2; TYROSINE 3 MONOOXYGENASE TRYPTOPHAN 5 MONOOXYGENASE ACTIVATION PROTEIN GAMMA POLYPEPTIDE; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2M; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; EMBRYO; GEL ELECTROPHORESIS; LIQUID CHROMATOGRAPHY; MOLECULAR DYNAMICS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ANIMALS; CELL ADHESION; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION; GENE SILENCING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NUCLEAR PROTEINS; PROTEOME; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

EID: 84875332337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059477     Document Type: Article

References (58)

1. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A, (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558-561.
2. Rowley JD, Golomb HM, Dougherty C, (1977) 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1: 549-550.
3. Grignani F, Valtieri M, Gabbianelli M, Gelmetti V, Botta R, et al. (2000) PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood 96: 1531-1537.
4. Bourdeau V, Baudry D, Ferbeyre G, (2009) PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Front Biosci 14: 475-485.
5. Li W, Rich T, Watson CJ, (2009) PML: a tumor suppressor that regulates cell fate in mammary gland. Cell Cycle 8: 2711-2717.
6. Geoffroy MC, Chelbi-Alix MK, (2011) Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res. 31: 145-158.
7. Salomoni P, Ferguson BJ, Wyllie AH, Rich T, (2008) New insights into the role of PML in tumour suppression. Cell Res. 18: 622-640.
8. Möller A, Schmitz ML, (2003) Viruses as hijackers of PML nuclear bodies. Arch Immunol Ther Exp (Warsz) 51: 295-300.
9. Borden KL, Culjkovic B, (2009) Perspectives in PML: a unifying framework for PML function. Front Biosci 14: 497-509.
10. Sardiello M, Cairo S, Fontanella B, Ballabio A, Meroni G, (2008) Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol 8: 225.
11. Geng Y, Monajembashi S, Shao A, Cui D, He W, et al. (2012) Contribution of the C-terminal regions of Promyelocytic leukemia protein (PML) isoform II and V to PML nuclear body formation. J Biol Chem 287: 30729-30742.
12. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, et al. (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279: 1547-1551.
13. Lin HK, Bergmann S, Pandolfi PP, (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431: 205-211.
14. Reineke EL, Kao HY (2009) Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int J Biol Sci: 366-376.
15. Lunardi A, Gaboli M, Giorgio M, Rivi R, Bygrave A, et al. (2011) A Role for PML in Innate Immunity. Genes Cancer 2: 10-19.
16. Kitowska A, Pawełczyk T, (2010) N-myc downstream regulated 1 gene and its place in the cellular machinery. Acta Biochim Pol 57: 15-21.
17. Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K, (2008) Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 1786: 87-104.
18. Lerner A, Grafi-Cohen M, Napso T, Azzam N, Fares F, (2012) The indolic diet-derivative, 3,3′-diindolylmethane, induced apoptosis in human colon cancer cells through upregulation of NDRG1. J Biomed Biotechnol 2012: 2561-2578.
19. Butler RN, Miller RA, Perry D, Carnes BA, Williams TF, et al. (2008) New model of health promotion and disease prevention for the 21st century. BMJ 337: a399.
20. Sikora E, Arendt T, Bennett M, Narita M, (2011) Impact of cellular senescence signature on ageing research. Ageing Res Rev 10: 146-152.
21. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, et al. (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279: 48930-48940.
22. del Pozo MA, Price LS, Alderson NB, Ren XD, Schwartz MA, (2000) Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 19: 2008-2014.
23. van Rijssel J, Hoogenboezem M, Wester L, Hordijk PL, Van Buul JD, (2012) The N-terminal DH-PH domain of Trio induces cell spreading and migration by regulating lamellipodia dynamics in a Rac1-dependent fashion. PLoS One 7: e29912.
24. Masuishi Y, Arakawa N, Kawasaki H, Miyagi E, Hirahara F, et al. (2011) Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma. FEBSJ 278: 1470-1483.
25. Kim A, Serada S, Enomoto T, Naka T, (2010) Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary. Expert Opin Ther Targets 14: 963-971.
26. Piljic A, Schultz C, (2006) Annexin A4 self-association modulates general membrane protein mobility in living cells. Mol Biol Cell 17: 3318-3328.
27. Kaetzel MA, Mo YD, Mealy TR, Campos B, Bergsma-Schutter W, et al. (2001) Phosphorylation mutants elucidate the mechanism of annexin IV-mediated membrane aggregation. Biochemistry 40: 4192-4199.
28. Junker M, Creutz CE, (1994) Ca(2+)-dependent binding of endonexin (annexin IV) to membranes: analysis of the effects of membrane lipid composition and development of a predictive model for the binding interaction. Biochemistry 33: 8930-8940.
29. Van Troys M, Huyck L, Leyman S, Dhaese S, Vandekerkhove J, et al. (2008) Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol 87: 649-667.
30. Lin CW, Yen ST, Chang HT, Chen SJ, Lai SL, et al. (2010) Loss of cofilin 1 disturbs actin dynamics, adhesion between enveloping and deep cell layers and cell movements during gastrulation in zebrafish. PLoS One 5: e15331.
31. Bamburg JR, (1999) Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu Rev Cell Dev Biol 15: 185-230.
32. Schreck KC, Gaiano N, (2009) PML: a tumor suppressor essential for neocortical development. Nat Neurosci. 12: 108-110.
33. Le Goff P, Le Dréan Y, Le Péron C, Le Jossic-Corcos C, Ainouche A, et al. (2004) Intracellular trafficking of heat shock factor 2. Exp Cell Res 294: 480-493.
34. Nefkens I, Negorev DG, Ishov AM, Michaelson JS, Yeh ET, et al. (2003) Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J Cell Sci 116: 513-524.
35. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN, (2001) Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 114: 29-36.
36. Regad T, Bellodi C, Nicotera P, Salomoni P, (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci 12: 132-140.
37. Sung KS, Lee YA, Kim ET, Lee SR, Ahn JH, et al. (2011) Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Exp Cell Res 317: 1060-1070.
38. Ullmann R, Chien CD, Avantaggiati ML, Muller S, (2012) An acetylation switch regulates SUMO-dependent protein interaction networks. Mol Cell 46: 759-770.
39. Yang Q, Liao L, Deng X, Chen R, Gray NS, et al. (2012) BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene doi: 10.1038/onc.2012.332.
40. Wang R, Li KM, Zhou CH, Xue JL, Ji CN, et al. (2011) Cdc20 mediates D-box-dependent degradation of Sp100. Biochem Biophys Res Commun. 415: 702-706.
41. Sang J, Yang K, Sun Y, Han Y, Cang H, et al. (2011) SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in a Sp1-dependent manner. Biochem J 435: 489-498.
42. Gibert B, Eckel B, Fasquelle L, Moulin M, Bouhallier F, et al. (2012) Knock down of heat shock protein 27 (HspB1) induces degradation of several putative client proteins. PLoS One 7: e29719.
43. You F, Sun H, Zhou X, Sun W, Liang S, et al. (2009) PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 10: 1300-1308.
44. Kondo H, Rabouille C, Newman R, Levine TP, Pappin D, et al. (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature 388: 75-78.
45. Chen Y, Choong LY, Lin Q, Philp R, Wong CH, et al. (2007) Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics 6: 2072-2087.
46. Tian XX, Chan JY, Pang JC, Chen J, He JH, et al. (1999) Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Br J Cancer 81: 994-1001.
47. Rana S, Maples PB, Senzer N, Nemunaitis J, (2008) Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8: 1461-1470.
48. Kang W, Tong JH, Chan AW, Lung RW, Chau SL, et al. (2012) Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer. PLoS One. 7: e33919.
49. Zhang L, Yang H, Xu J, (2011) Gene expression significance in personalized medicine of non-small-cell lung cancer and gene expression analyzing platforms. Curr Drug Metab 12: 455-459.
50. Kobayashi T, Aoki Y, Niihori T, Cavé H, Verloes A, et al. (2010) Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation. Hum Mutat 31: 284-294.
51. Capobianco V, Nardelli C, Ferrigno M, Iaffaldano L, Pilone V, et al. (2012) miRNA and Protein Expression Profiles of Visceral Adipose Tissue Reveal miR-141/YWHAG and miR-520e/RAB11A as Two Potential miRNA/Protein Target Pairs Associated with Severe Obesity. J Proteome Res 11: 3358-3369.
52. Sun HJ, Bahk YY, Choi YR, Shim JH, Han SH, et al. (2006) A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell. J Orthop Res 24: 2059-2071.
53. Liu L, Yuan W, Wang J, (2010) Mechanisms for osteogenic differentiation of human mesenchymal stem cells induced by fluid shear stress. Biomech Model Mechanobiol 9: 659-670.
54. Tang MK, Liu GJ, Chui YL, Chan JYH, Lee KKH, (2009) Livers over-expressing BRE transgene are under heightened state of stress-response, as revealed by comparative proteomics. Proteomics: Clinical Application 3: 1362-1370.
55. Yau WWY, Tang MK, Chen E, Yao Y, Wong IWC, et al. (2011) Cardiogenol C can induce mouse hair bulge progenitor cells to transdifferentiate into cardiomyocyte-like cells. Proteome Science 9: 1-16.
56. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-33.
57. Webb SE, Lee KKH, Tang MK, Ede DA, (1997) Fibroblast Growth Factors 2 and 4 Stimulate Migration of Mouse Embryonic Limb Myogenic Cells. Developmental Dynamics 209: 206-216.
58. Tang MK, Wang CM, Shan SW, Chui YL, Ching AK, et al. (2006) Comparative proteomic analysis reveals a function of the novel death receptor-associated protein BRE in the regulation of Prohibitin and p53 expression and proliferation. Proteomics: 2376-2385.